Who Owns ZimVie Company?

Who owns ZimVie now?

The company formed from Zimmer Biomet’s March 1, 2022 spin-off focuses on dental implants and biomaterials after divesting spine assets. Headquartered in Westminster, Colorado, ZimVie targets growth in an ~$8 billion global dental market.

Ownership shifted from a diversified medtech base toward institutional investors and private equity after a 2024 sale of spine operations to H.I.G. Capital for $375 million, tightening ZimVie’s investor profile. See ZimVie Porter's Five Forces Analysis for product context.

ZimVie’s founding was a corporate spin-off from Zimmer Biomet completed in early 2022, creating a public company whose initial ownership mirrored Zimmer Biomet’s shareholder base rather than a concentrated founder stake. Zimmer Biomet shareholders received one ZimVie share for every ten ZBH shares, producing an initial float of approximately 26.1 million shares.

Origin of ownership

Ownership was distributed to Zimmer Biomet shareholders via a pro rata spin-off, not through founder equity grants or venture rounds.

Initial share float

The spin-off resulted in an initial public float of roughly 26.1 million ZimVie common shares.

Leadership founders

Executives from Zimmer Biomet, led by Vinit Asar as CEO, functioned as ZimVie’s founding management team.

Early investors

Early backers were largely institutional holders of the parent—large funds such as BlackRock, Vanguard, and State Street appeared among top holders.

Governance and agreements

Transition agreements, including tax and transition service agreements, governed the separation and operational independence.

Equity concentration

The initial equity split reflected Zimmer Biomet’s institutional and retail ownership rather than a founder-led concentration common in IPOs.

Early SEC filings showed no founder stock carve-outs or angel rounds; the corporate distribution structure meant there were no ownership disputes at spin-off and the largest shareholders immediately post-distribution were major institutional investors listed in public filings.

Key facts — Founders and early ownership

Concise points on how ZimVie was created and who owned it initially.

• Spin-off ratio: one ZimVie share per ten Zimmer Biomet (ZBH) shares.
• Initial float: approximately 26.1 million shares.
• Founding team: Zimmer Biomet executives led by Vinit Asar as CEO.
• Early major holders: institutional funds mirrored from Zimmer Biomet (e.g., BlackRock, Vanguard, State Street).

For more on strategic context and the company’s post-spin corporate moves, see Growth Strategy of ZimVie.

Complete ZimVie Strategy Bundle

• 6 Full Frameworks, 1 Company – All Pre-Researched
• Each Framework Fully Sourced with Real Company Data
• Built for Strategy Courses, Case Studies & MBA Programs
• Adapt to Your Assignment – No Starting from Scratch
• 6 Frameworks: SWOT, PESTLE, Porter's, BMC, BCG and 4P's

GET FULL BUNDLE

Key corporate events reshaped ZimVie ownership: the 2022 NASDAQ listing under ZIMV and the mid-2024 sale of the global spine business to H.I.G. Capital for $375,000,000 (including a $315,000,000 cash component and a $60,000,000 promissory note), which funded debt reduction and refocused the company on dental technology.

By Q3 2025 the ownership mix reflected that strategic pivot: institutional holders owned over 92% of outstanding shares, while insider ownership remained below 3%, concentrated in executive and board equity grants.

Major stakeholders and ownership profile

Institutional concentration has become the defining feature of ZimVie ownership, with a few asset managers controlling meaningful stakes that influence strategic direction.

• BlackRock Inc.: approximately 15.2% of outstanding shares
• The Vanguard Group: roughly 10.8%
• Dimensional Fund Advisors + State Street Global Advisors: combined ~12.5%
• Insider ownership: typically under 3%, aligned via equity grants

For additional context on ZimVie's business model and revenue mix after the divestiture, see Revenue Streams & Business Model of ZimVie

From PESTLE Factors to Full Strategy Bundle

• PESTLE + SWOT + Porter's + BCG + BMC + 4P's in One Bundle
• Every Strategic Angle Covered – Nothing Left to Research
• Pre-filled with Company-Specific Research
• No Missing Sections for Your Case Study
• One Download Covers Your Entire Company Analysis

GET COMPLETE BUNDLE

The ZimVie board blends medical-device, dental-care and finance expertise, chaired by Vinit Asar with independent directors including Vafa Jamali and Karen M. Parkhill; governance follows a one-share-one-vote model without dual-class or golden shares, aligning voting power with economic interest.

The board answers to a broadly dispersed institutional shareholder base; as of year-end 2025 the largest institutional holders each held under 10%, reinforcing that no single majority owner controls ZimVie and that voting power reflects share ownership.

Board responsiveness and voting dynamics

The one-share-one-vote structure and a predominantly institutional shareholder registry have driven strategic shifts, including the divestiture of the spine segment to sharpen focus on dental and higher-margin growth.

• Governance: one-share-one-vote, no dual-class shares
• Largest institutional investors: each with sub-10% stakes as of 2025
• Board acted on shareholder pressure to divest spine to boost margins
• Independent directors represent broad shareholder interests, limiting single-owner control

For additional context on ZimVie ownership and strategy see Marketing Strategy of ZimVie

ZimVie Business Model + Strategy Bundle

• Ideal for Essays, Case Studies & Slides
• Get BCG, SWOT, PESTLE, Porter's, 4P's Mix & BMC Together
• Company-Specific Content Already Organized
• One Bundle Replaces Days of Independent Research
• Buy the Bundle Once. Use Across All Your Assignments

GET COMPLETE ANALYSIS

The past 24 months show a clear rotation in ZimVie ownership toward investors focused on dental-only growth, driven by the company shedding noncore assets and reinforcing its position in dental implants and biomaterials.

Ownership dynamics through 2025 reflect stabilization and strategic positioning: incumbents focused on dental growth now dominate ZimVie ownership, while private equity and larger dental conglomerates monitor consolidation opportunities in the fragmented dental technology market.

Ownership rotation

Institutional holders shifted toward dental specialists; major mutual funds and healthcare-focused ETFs increased exposure in 2024–2025.

Debt reduction effects

Proceeds from the spine divestiture and targeted debt paydown improved leverage ratios, enabling potential buybacks and making ZimVie more attractive to acquirers.

Acquisition speculation

Analysts in late 2025 flagged ZimVie as a likely target for consolidation by larger dental groups or PE sponsors seeking scale in implants and biomaterials.

Investor relations transparency

Public filings and quarterly disclosures in 2025 clarified shareholder mix and reinforced ZimVie ownership trends; see Mission, Vision & Core Values of ZimVie for corporate context.

From Five Forces to Full Company Analysis

• Includes SWOT, PESTLE, BMC, BCG and 4P's
• Pre-Researched with Company-Specific Data
• Best Value for a Complete Analysis
• Ready to Adapt for Your Case Study
• Ready for Essays and Slidesd

GET FULL BUNDLE